Clinical Trial

Argentine Registry of Crohn's Disease and Ulcerative Colitis

Study acronym: RADECCU
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
RADECCU is a strictly observational IBD registry in Argentina. The registry is open to all practicing gastroenterologist in the country grouped within the Argentinean Crohn's and Ulcerative Colitis Group (GADECCU). The registry will include outcomes of routine clinical practice of patients with IBD including the pediatric and adult population.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-27.
Trial Details
NCT Number NCT07155148
Lead Sponsor Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
Conditions Epidemiology, Inflammatory Bowel Disease (IBD), Therapy
Enrollment 4,250 participants
Start Date 2023-07-14
Primary Completion 2025-11-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-23